Electroencephalography and analgesics - PubMed
Review
Electroencephalography and analgesics
Lasse Paludan Malver et al. Br J Clin Pharmacol. 2014 Jan.
Abstract
To assess centrally mediated analgesic mechanisms in clinical trials with pain patients, objective standardized methods such as electroencephalography (EEG) has many advantages. The aim of this review is to provide the reader with an overview of present findings in analgesics assessed with spontaneous EEG and evoked brain potentials (EPs) in humans. Furthermore, EEG methodologies will be discussed with respect to translation from animals to humans and future perspectives in predicting analgesic efficacy. We searched PubMed with MeSH terms 'analgesics', 'electroencephalography' and 'evoked potentials' for relevant articles. Combined with a search in their reference lists 15 articles on spontaneous EEG and 55 papers on EPs were identified. Overall, opioids produced increased activity in the delta band in the spontaneous EEG, but increases in higher frequency bands were also seen. The EP amplitudes decreased in the majority of studies. Anticonvulsants used as analgesics showed inconsistent results. The N-methyl-D-aspartate receptor antagonist ketamine showed an increase in the theta band in spontaneous EEG and decreases in EP amplitudes. Tricyclic antidepressants increased the activity in the delta, theta and beta bands in the spontaneous EEG while EPs were inconsistently affected. Weak analgesics were mainly investigated with EPs and a decrease in amplitudes was generally observed. This review reveals that both spontaneous EEG and EPs are widely used as biomarkers for analgesic drug effects. Methodological differences are common and a more uniform approach will further enhance the value of such biomarkers for drug development and prediction of treatment response in individual patients.
Keywords: analgesics; electroencephalography; evoked potentials; pain; pharmacologic actions.
© 2013 The British Pharmacological Society.
Figures

Spontaneous EEG representing the overall cortical neural processing is a mix of several brain oscillations. (A) Oscillations can be presented in a time domain. (B) The frequency distribution can be presented in a time–frequency domain. (C) Traditionally the oscillations are decomposed into specific frequency bands, with the slowest oscillations in the delta band (1.5–6 Hz) and the fastest oscillations into the beta band (12.5–30 Hz). Thus the frequency distribution can be presented in the frequency domain as the relative contributions of each frequency band to the overall power of the EEG

Interactions among brain regions hypothesized to constitute the homeostatic system that generates and regulates the electroencephalographic power spectrum

Evoked brain potential during painful electrical stimulation at the median nerve. The potential is an average of several repeated and identical stimulations. The cortical processing of the painful stimuli is traditionally assessed as amplitude and latency characteristics of both negative and positive peaks
Similar articles
-
Gram M, Graversen C, Nielsen AK, Arendt-Nielsen T, Mørch CD, Andresen T, Drewes AM. Gram M, et al. Br J Clin Pharmacol. 2013 Dec;76(6):951-63. doi: 10.1111/bcp.12120. Br J Clin Pharmacol. 2013. PMID: 23521205 Free PMC article. Clinical Trial.
-
Objective methods for the assessment of the spinal and supraspinal effects of opioids.
Fischer IW, Hansen TM, Lelic D, Brokjaer A, Frøkjær J, Christrup LL, Olesen AE. Fischer IW, et al. Scand J Pain. 2017 Jan;14:15-24. doi: 10.1016/j.sjpain.2016.10.001. Epub 2016 Nov 1. Scand J Pain. 2017. PMID: 28850426 Review.
-
Graversen C, Malver LP, Kurita GP, Staahl C, Christrup LL, Sjøgren P, Drewes AM. Graversen C, et al. Basic Clin Pharmacol Toxicol. 2015 May;116(5):414-22. doi: 10.1111/bcpt.12330. Epub 2014 Oct 21. Basic Clin Pharmacol Toxicol. 2015. PMID: 25250670 Clinical Trial.
-
García PS, Kreuzer M, Hight D, Sleigh JW. García PS, et al. Br J Anaesth. 2021 Feb;126(2):445-457. doi: 10.1016/j.bja.2020.10.036. Br J Anaesth. 2021. PMID: 33461725 Review.
-
Spontaneous and TMS-related EEG changes as new biomarkers to measure anti-epileptic drug effects.
Biondi A, Rocchi L, Santoro V, Rossini PG, Beatch GN, Richardson MP, Premoli I. Biondi A, et al. Sci Rep. 2022 Feb 4;12(1):1919. doi: 10.1038/s41598-022-05179-x. Sci Rep. 2022. PMID: 35121751 Free PMC article.
Cited by
-
Sensory testing and topical capsaicin can characterize patients with rheumatoid arthritis.
Anders B, Anders M, Kreuzer M, Zinn S, Fricker L, Maier C, Wolters M, Köhm M, Behrens F, Walter C. Anders B, et al. Clin Rheumatol. 2022 Aug;41(8):2351-2360. doi: 10.1007/s10067-022-06185-0. Epub 2022 Apr 30. Clin Rheumatol. 2022. PMID: 35499773 Free PMC article.
-
An Electroencephalography Bioassay for Preclinical Testing of Analgesic Efficacy.
Koyama S, LeBlanc BW, Smith KA, Roach C, Levitt J, Edhi MM, Michishita M, Komatsu T, Mashita O, Tanikawa A, Yoshikawa S, Saab CY. Koyama S, et al. Sci Rep. 2018 Nov 6;8(1):16402. doi: 10.1038/s41598-018-34594-2. Sci Rep. 2018. PMID: 30401974 Free PMC article.
-
Substance-dependent EEG during recovery from anesthesia and optimization of monitoring.
Lipp M, Schneider G, Kreuzer M, Pilge S. Lipp M, et al. J Clin Monit Comput. 2024 Jun;38(3):603-612. doi: 10.1007/s10877-023-01103-4. Epub 2023 Dec 18. J Clin Monit Comput. 2024. PMID: 38108943 Free PMC article.
-
Kodama K, Takamoto K, Nishimaru H, Matsumoto J, Takamura Y, Sakai S, Ono T, Nishijo H. Kodama K, et al. Front Syst Neurosci. 2019 Nov 13;13:68. doi: 10.3389/fnsys.2019.00068. eCollection 2019. Front Syst Neurosci. 2019. PMID: 31798422 Free PMC article.
-
Grosen K, Olesen AE, Gram M, Jonsson T, Kamp-Jensen M, Andresen T, Nielsen C, Pozlep G, Pfeiffer-Jensen M, Morlion B, Drewes AM. Grosen K, et al. PLoS One. 2017 Feb 3;12(2):e0171723. doi: 10.1371/journal.pone.0171723. eCollection 2017. PLoS One. 2017. PMID: 28158269 Free PMC article.
References
-
- Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, Kvarstein G, Stubhaug A. Assessment of pain. Br J Anaesth. 2008;101:17–24. - PubMed
-
- Olesen AE, Andresen T, Staahl C, Drewes AM. Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs. Pharmacol Rev. 2012;64:722–779. - PubMed
-
- Saab C. Visualizing the complex brain dynamics of chronic pain. J Neuroimmune Pharmacol. 2012 [Epub ahead of print] - PubMed
-
- Prichep LS, John ER, Howard B, Merkin H, Hiesiger EM. Evaluation of the pain matrix using EEG source localization: a feasibility study. Pain Med. 2011;12:1241–1248. - PubMed
-
- Chizh BA, Priestley T, Rowbotham M, Schaffler K. Predicting therapeutic efficacy – experimental pain in human subjects. Brain Res Rev. 2009;60:243–254. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources